-
1
-
-
0025340363
-
The natural course of central retinal vein occlusion
-
Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C: The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110:118-123.
-
(1990)
Am J Ophthalmol
, vol.110
, pp. 118-123
-
-
Quinlan, P.M.1
Elman, M.J.2
Bhatt, A.K.3
Mardesich, P.4
Enger, C.5
-
2
-
-
0020520636
-
Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion
-
Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506.
-
(1983)
Ophthalmology
, vol.90
, pp. 488-506
-
-
Hayreh, S.S.1
Rojas, P.2
Podhajsky, P.3
Montague, P.4
Woolson, R.F.5
-
3
-
-
0018740720
-
The natural course of central retinal vein occlusion
-
Zegarra H, Gutman FA, Conforto J: The natural course of central retinal vein occlusion. Ophthalmology 1979;86:1931-1942.
-
(1979)
Ophthalmology
, vol.86
, pp. 1931-1942
-
-
Zegarra, H.1
Gutman, F.A.2
Conforto, J.3
-
4
-
-
0028802678
-
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion
-
Central Vein Occlusion Study Group N Report
-
Central Vein Occlusion Study Group N Report: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995;102: 1434-1444.
-
(1995)
Ophthalmology
, vol.102
, pp. 1434-1444
-
-
-
5
-
-
0031955016
-
Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion
-
Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM: Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-167.
-
(1998)
Br J Ophthalmol
, vol.82
, pp. 162-167
-
-
Chen, H.C.1
Wiek, J.2
Gupta, A.3
Luckie, A.4
Kohner, E.M.5
-
6
-
-
0024311203
-
A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution
-
Hansen LL, Wiek J, Wiederholt M: A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989;73:895-899.
-
(1989)
Br J Ophthalmol
, vol.73
, pp. 895-899
-
-
Hansen, L.L.1
Wiek, J.2
Wiederholt, M.3
-
7
-
-
0025928843
-
Hämodilution bei Patienten mit Zentralvenenthrombose der Retina
-
Wolf S, Arend B, Bertram B, Schulte K, Kaufhold F, Teping C, Reim M: Hämodilution bei Patienten mit Zentralvenenthrombose der Retina. Fortschr Ophthalmol 1991;88:35-43.
-
(1991)
Fortschr Ophthalmol
, vol.88
, pp. 35-43
-
-
Wolf, S.1
Arend, B.2
Bertram, B.3
Schulte, K.4
Kaufhold, F.5
Teping, C.6
Reim, M.7
-
8
-
-
0028011852
-
Hemodilution therapy in central retinal vein occlusion: One-year results of a prospective randomized study
-
Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, Reim M: Hemodilution therapy in central retinal vein occlusion: One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994;232: 33-39.
-
(1994)
Graefes Arch Clin Exp Ophthalmol
, vol.232
, pp. 33-39
-
-
Wolf, S.1
Arend, O.2
Bertram, B.3
Remky, A.4
Schulte, K.5
Wald, K.J.6
Reim, M.7
-
9
-
-
0027935493
-
A randomised, double masked study on the treatment of retinal vein occlusion with troxerutin
-
Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM: A randomised, double masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994;118:421-429.
-
(1994)
Am J Ophthalmol
, vol.118
, pp. 421-429
-
-
Glacet-Bernard, A.1
Coscas, G.2
Chabanel, A.3
Zourdani, A.4
Lelong, F.5
Samama, M.M.6
-
10
-
-
0019768239
-
Central retinal vein occlusion. A prospective histopathologic study of 29 eyes in 28 cases
-
Green WR, Chan CC, Hutchins GM, Terry JM: Central retinal vein occlusion. A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
-
(1981)
Retina
, vol.1
, pp. 27-55
-
-
Green, W.R.1
Chan, C.C.2
Hutchins, G.M.3
Terry, J.M.4
-
11
-
-
0018938932
-
Clinicopathologic case report of bilateral central retinal vein occlusion in Reye's syndrome
-
Smith P, Green WR, Miller NR, Terry JM: Clinicopathologic case report of bilateral central retinal vein occlusion in Reye's syndrome. Arch Ophthalmol 1980;98:1256-1260.
-
(1980)
Arch Ophthalmol
, vol.98
, pp. 1256-1260
-
-
Smith, P.1
Green, W.R.2
Miller, N.R.3
Terry, J.M.4
-
12
-
-
0023258694
-
Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
-
Chesebro JH, Knatterud G, Roberts R: Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987;76:142-154.
-
(1987)
Circulation
, vol.76
, pp. 142-154
-
-
Chesebro, J.H.1
Knatterud, G.2
Roberts, R.3
-
13
-
-
0026607185
-
ISIS-3: A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected myocardial infarction
-
ISIS-3 (Third International Study of Infarct Survival) Collaborative Group: ISIS-3: A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected myocardial infarction. Lancet 1993;339:753-770.
-
(1993)
Lancet
, vol.339
, pp. 753-770
-
-
-
14
-
-
0027240597
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
-
The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
-
(1993)
N Engl J Med
, vol.329
, pp. 673-682
-
-
-
15
-
-
0027424433
-
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
-
The GUSTO angiographic investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329: 1615-1622.
-
(1993)
N Engl J Med
, vol.329
, pp. 1615-1622
-
-
-
16
-
-
0021989853
-
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Report from the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator
-
Verstraete M, Bernard R, Bory M: Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Report from the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Lancet 1985;i:842-847.
-
(1985)
Lancet
, vol.1
, pp. 842-847
-
-
Verstraete, M.1
Bernard, R.2
Bory, M.3
-
17
-
-
0027446870
-
Alteplase versus heparin in acute pulmonary embolsim: Randomised trial assessing right-ventricular function and pulmonary perfusion
-
Goldhaber SZ: Alteplase versus heparin in acute pulmonary embolsim: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-511.
-
(1993)
Lancet
, vol.341
, pp. 507-511
-
-
Goldhaber, S.Z.1
-
18
-
-
0025274774
-
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis
-
Goldhaber SZ, Meyerovitz MF, Green D: Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990;88:235-240.
-
(1990)
Am J Med
, vol.88
, pp. 235-240
-
-
Goldhaber, S.Z.1
Meyerovitz, M.F.2
Green, D.3
-
19
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke rt-PA Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
20
-
-
0032537068
-
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs
-
The Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators: A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998;338:1105-1111.
-
(1998)
N Engl J Med
, vol.338
, pp. 1105-1111
-
-
-
21
-
-
0032138123
-
Systemische Lysetherapie bei retinalen Gefässverschlüssen
-
Hattenbach LO: Systemische Lysetherapie bei retinalen Gefässverschlüssen. Ophthalmologe 1998;95:568-575.
-
(1998)
Ophthalmologe
, vol.95
, pp. 568-575
-
-
Hattenbach, L.O.1
-
22
-
-
0031716493
-
Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion
-
Hattenbach LO, Steinkamp GWK, Scharrer I, Ohrloff C: Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998; 212:394-398.
-
(1998)
Ophthalmologica
, vol.212
, pp. 394-398
-
-
Hattenbach, L.O.1
Steinkamp, G.W.K.2
Scharrer, I.3
Ohrloff, C.4
-
23
-
-
0017231611
-
Streptokinase in central retinal vein occlusion: A controlled clinical trial
-
Kohner EM, Pettit JE, Hamilton AM: Streptokinase in central retinal vein occlusion: A controlled clinical trial. Br Med J 1976;1:550-553.
-
(1976)
Br Med J
, vol.1
, pp. 550-553
-
-
Kohner, E.M.1
Pettit, J.E.2
Hamilton, A.M.3
-
24
-
-
0023680053
-
Lysetherapie mit rt-PA bei Patienten mit Stamm- oder Zentralvenenocclusion der Retina
-
Kreutzer A, Brunner R, Schäfer H-J, Sickel W, Auel H, Hossmann V: Lysetherapie mit rt-PA bei Patienten mit Stamm- oder Zentralvenenocclusion der Retina. Fortschr Ophthalmol 1988;85:511-513.
-
(1988)
Fortschr Ophthalmol
, vol.85
, pp. 511-513
-
-
Kreutzer, A.1
Brunner, R.2
Schäfer, H.-J.3
Sickel, W.4
Auel, H.5
Hossmann, V.6
-
26
-
-
0026742376
-
Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes
-
Brott TG, Haley EC Jr, Levy DE: Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-640.
-
(1992)
Stroke
, vol.23
, pp. 632-640
-
-
Brott, T.G.1
Haley Jr., E.C.2
Levy, D.E.3
-
27
-
-
0026639662
-
Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset
-
Haley EC Jr, Levy DE, Brott TG: Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992;23:641-645.
-
(1992)
Stroke
, vol.23
, pp. 641-645
-
-
Haley Jr., E.C.1
Levy, D.E.2
Brott, T.G.3
-
28
-
-
0031674570
-
Heparin cofactor II deficiency in central retinal vein occlusion
-
Hattenbach LO, Klais C, Scharrer I: Heparin cofactor II deficiency in central retinal vein occlusion. Acta Ophthalmol Scand 1998;76: 758-759.
-
(1998)
Acta Ophthalmol Scand
, vol.76
, pp. 758-759
-
-
Hattenbach, L.O.1
Klais, C.2
Scharrer, I.3
-
29
-
-
0029920962
-
Prognostic factors for retinal vein occlusion
-
Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM: Prognostic factors for retinal vein occlusion. Ophthalmology 1996;103:551-560.
-
(1996)
Ophthalmology
, vol.103
, pp. 551-560
-
-
Glacet-Bernard, A.1
Coscas, G.2
Chabanel, A.3
Zourdani, A.4
Lelong, F.5
Samama, M.M.6
-
30
-
-
0023875143
-
Behandlungsversuche der Zentralvenenthrombose der Netzhaut mit Plasminogen-Aktivator (rt-PA)
-
Reim M, Bertram B, Wolf S: Behandlungsversuche der Zentralvenenthrombose der Netzhaut mit Plasminogen-Aktivator (rt-PA). Klin Wochenschr 1988;66:143-149.
-
(1988)
Klin Wochenschr
, vol.66
, pp. 143-149
-
-
Reim, M.1
Bertram, B.2
Wolf, S.3
-
31
-
-
0031733169
-
Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit
-
Larsson J, Carlson J, Olsson SB: Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit. Br J Ophthalmol 1998;82:1438-1440.
-
(1998)
Br J Ophthalmol
, vol.82
, pp. 1438-1440
-
-
Larsson, J.1
Carlson, J.2
Olsson, S.B.3
-
32
-
-
0024507916
-
Tissue plasminogen activator in the treatment of experimental retinal vein occlusion
-
Oncel M, Peyman GA, Khoobehi B: Tissue plasminogen activator in the treatment of experimental retinal vein occlusion. Retina 1989; 9:1-7.
-
(1989)
Retina
, vol.9
, pp. 1-7
-
-
Oncel, M.1
Peyman, G.A.2
Khoobehi, B.3
-
33
-
-
0029127602
-
Central retinal vein thrombosis associated with resistance to activated protein C
-
Dhote R, Bachmeyer C, Horellou MH, Toulon P, Christoforov B: Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 1995;120:388-389.
-
(1995)
Am J Ophthalmol
, vol.120
, pp. 388-389
-
-
Dhote, R.1
Bachmeyer, C.2
Horellou, M.H.3
Toulon, P.4
Christoforov, B.5
-
34
-
-
0026168395
-
Ocular thrombosis associated with antiphospholipid antibodies
-
Galetta SL, Plock GL, Kushner MJ, Wyszynski RE, Bruckner AJ: Ocular thrombosis associated with antiphospholipid antibodies. Ann Ophthalmol 1991;23:207-212.
-
(1991)
Ann Ophthalmol
, vol.23
, pp. 207-212
-
-
Galetta, S.L.1
Plock, G.L.2
Kushner, M.J.3
Wyszynski, R.E.4
Bruckner, A.J.5
-
35
-
-
0029927375
-
Activated protein C resistance in young adults with central retinal vein occlusion
-
Larsson J, Olafsdottir E, Bauer B: Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996;80:200-202.
-
(1996)
Br J Ophthalmol
, vol.80
, pp. 200-202
-
-
Larsson, J.1
Olafsdottir, E.2
Bauer, B.3
-
36
-
-
0029908725
-
Isovolemic hemodilution increases retinal tissue oxygen tension
-
Neely KA, Ernest JT, Goldstick TK, Linsenmeier RA, Moss J: Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol 1996;234:688-694.
-
(1996)
Graefes Arch Clin Exp Ophthalmol
, vol.234
, pp. 688-694
-
-
Neely, K.A.1
Ernest, J.T.2
Goldstick, T.K.3
Linsenmeier, R.A.4
Moss, J.5
-
37
-
-
0025812589
-
Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis
-
Anderson JL, Karagounis L, Allan A, Bradford MJ, Menlove RL, Pryor TA: Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991;68:166-170.
-
(1991)
Am J Cardiol
, vol.68
, pp. 166-170
-
-
Anderson, J.L.1
Karagounis, L.2
Allan, A.3
Bradford, M.J.4
Menlove, R.L.5
Pryor, T.A.6
-
38
-
-
0024441545
-
The use of tissue plasminogen activator for acute myocardial infarction in the elderly: Results from the Thrombolysis in Myocardial Infarction Phase I Open-Label Studies, and the Thrombolysis in Myocardial Infarction Phase II Pilot Study
-
Chaitman BR, Thompson B, Wittry MD, Stump D, Hamilton WP, Hillis LD, Dwyer JG, Solomon RE, Knatterud GL for the TIMI Investigators: The use of tissue plasminogen activator for acute myocardial infarction in the elderly: Results from the Thrombolysis in Myocardial Infarction Phase I Open-Label Studies, and the Thrombolysis in Myocardial Infarction Phase II Pilot Study. J Am Coll Cardiol 1989; 14:1159-1165.
-
(1989)
J Am Coll Cardiol
, vol.14
, pp. 1159-1165
-
-
Chaitman, B.R.1
Thompson, B.2
Wittry, M.D.3
Stump, D.4
Hamilton, W.P.5
Hillis, L.D.6
Dwyer, J.G.7
Solomon, R.E.8
Knatterud, G.L.9
-
39
-
-
0026100158
-
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study: Thrombolysis in Myocardial Infarction; Phase II, Pilot and Clinical Trial
-
Gore JM, Sloan M, Price TR, Randall AMY, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML, and the TIMI Investigators: Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study: Thrombolysis in Myocardial Infarction; Phase II, Pilot and Clinical Trial. Circulation 1991;83:448-459.
-
(1991)
Circulation
, vol.83
, pp. 448-459
-
-
Gore, J.M.1
Sloan, M.2
Price, T.R.3
Randall, A.M.Y.4
Bovill, E.5
Collen, D.6
Forman, S.7
Knatterud, G.L.8
Sopko, G.9
Terrin, M.L.10
-
40
-
-
0026507306
-
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
-
Sloan M, Gore JM: Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis. Am J Cardiol 1992;69:21A-38A.
-
(1992)
Am J Cardiol
, vol.69
-
-
Sloan, M.1
Gore, J.M.2
|